Cargando…

Association between hypertension and the prevalence of liver steatosis and fibrosis

BACKGROUND: Hypertension (HTN) and non-alcoholic fatty liver disease (NAFLD) frequently coexist and share pathophysiological symptoms. Based on the liver stiffness measurement and controlled attenuation parameter obtained by performing liver transient ultrasound elastography (TUE), we determined the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Huanjie, Yu, Hao, Zhao, Yisheng, Chen, Jinhong, Liu, Zhichao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116756/ https://www.ncbi.nlm.nih.gov/pubmed/37081417 http://dx.doi.org/10.1186/s12902-023-01318-1

Ejemplares similares

Association between type 2 diabetes status and prevalence of liver steatosis and fibrosis among adults aged ≥ 40 years
por: Chen, Jun, et al.
Publicado: (2022)

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
por: Xie, Ruijie, et al.
Publicado: (2022)

High prevalence of metabolic diseases, liver steatosis and fibrosis among Chinese psychiatric patients
por: Li, Huixia, et al.
Publicado: (2023)

Association between dietary inflammation index and hypertension in participants with different degrees of liver steatosis
por: Wu, Wenhao, et al.
Publicado: (2023)

Association Between Skeletal Muscle Mass and Severity of Steatosis and Fibrosis in Non-alcoholic Fatty Liver Disease
por: Guo, Wen, et al.
Publicado: (2022)

Update of liver fibrosis and steatosis with transient elastography (Fibroscan)
por: Wong, Grace Lai-Hung
Publicado: (2013)

The effect of steatosis and fibrosis on blunt force vulnerability of the liver
por: Simon, Gábor, et al.
Publicado: (2020)

Hepatorenal index for grading liver steatosis with concomitant fibrosis
por: Stahlschmidt, Fabio Lucio, et al.
Publicado: (2021)

Prevalence and Determinants of Undiagnosed Liver Steatosis and Fibrosis in a Nationally Representative Sample of US Adults
por: Bhattacharyya, Mehul, et al.
Publicado: (2023)

TAK1: A Molecular Link Between Liver Inflammation, Fibrosis, Steatosis, and Carcinogenesis
por: Wang, Weijun, et al.
Publicado: (2021)

Liver steatosis, cardiac and renal fibrosis, and hypertension in overweight rats: Angiotensin-(3–4)-sensitive hepatocardiorenal syndrome
por: Crisóstomo, Thuany, et al.
Publicado: (2022)

Liver steatosis induces portal hypertension regardless of fibrosis in patients with NAFLD: A proof of concept case report
por: Rivera-Esteban, Jesús, et al.
Publicado: (2022)

Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis
por: Turola, Elena, et al.
Publicado: (2015)

Is endocan a novel potential biomarker of liver steatosis and fibrosis?
por: Klisić, Aleksandra, et al.
Publicado: (2020)

Association between Gastroesophageal Reflux Disease and Elastographic Parameters of Liver Steatosis and Fibrosis: Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Clinical Relevance of Vitamins and Carotenoids With Liver Steatosis and Fibrosis Detected by Transient Elastography in Adults
por: Liu, Xiaohui, et al.
Publicado: (2021)

Prevalence of advanced liver fibrosis and steatosis in type-2 diabetics with normal transaminases: A prospective cohort study
por: Makker, Jasbir, et al.
Publicado: (2021)

PREVALENCE OF HEPATIC STEATOSIS AMONG CHILDREN AND ADOLESCENTS WITH CYSTIC FIBROSIS AND ITS ASSOCIATION WITH NUTRITIONAL STATUS
por: Gobato, Amanda Oliva, et al.
Publicado: (2019)

The Impact of PNPLA3 rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection
por: Scheiner, Bernhard, et al.
Publicado: (2015)

Bile Acid Changes Associated With Liver Fibrosis and Steatosis in the Mexican‐American Population of South Texas
por: Kwan, Suet Ying, et al.
Publicado: (2020)

The association of hepatic steatosis and fibrosis with heart failure and mortality
por: Park, Jiyun, et al.
Publicado: (2021)

Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study
por: Abeysekera, Kushala W M, et al.
Publicado: (2020)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis
por: Rabindranath, Madhumitha, et al.
Publicado: (2023)

Intestinal Pgc1α ablation protects from liver steatosis and fibrosis
por: Piccinin, Elena, et al.
Publicado: (2023)

Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis
por: Pingitore, Piero, et al.
Publicado: (2019)

Liver Fibrosis and Steatosis in Alström Syndrome: A Genetic Model for Metabolic Syndrome
por: Bettini, Silvia, et al.
Publicado: (2021)

Nitrooleic Acid Attenuates Lipid Metabolic Disorders and Liver Steatosis in DOCA-Salt Hypertensive Mice
por: Wang, Haiping, et al.
Publicado: (2015)

Prevalence of hepatic steatosis and metabolic associated fatty liver disease among female breast cancer survivors
por: Tian, Shen, et al.
Publicado: (2022)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Association between weight-adjusted-waist index with hepatic steatosis and liver fibrosis: a nationally representative cross-sectional study from NHANES 2017 to 2020
por: Shen, Yun, et al.
Publicado: (2023)

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis
por: Allende, Daniela S, et al.
Publicado: (2021)

Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics
por: Chen, Jinhong, et al.
Publicado: (2021)

Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Association between Dietary Fatty Acid Intake and Liver Steatosis and Fibrosis in a Sample of Mexican-Origin Hispanic Adults with Overweight or Obesity
por: Lopez-Pentecost, Melissa, et al.
Publicado: (2023)

Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction
por: Choi, Jaehyuk, et al.
Publicado: (2022)

Per‐ and polyfluoroalkyl substances activate UPR pathway, induce steatosis and fibrosis in liver cells
por: Qi, Qi, et al.
Publicado: (2022)

Relationship between Serum Cytokeratin-18, Control Attenuation Parameter, NAFLD Fibrosis Score, and Liver Steatosis in Nonalcoholic Fatty Liver Disease
por: Kosasih, Sumitro, et al.
Publicado: (2018)

High-Sensitive CRP Correlates With the Severity of Liver Steatosis and Fibrosis in Obese Patients With Metabolic Dysfunction Associated Fatty Liver Disease
por: Zhu, Cuiling, et al.
Publicado: (2022)

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Qu, Ying, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_risr64idc1rh6bvhlch09jam79